Head of Health Technology Assessment / Group Leader+31205126197 firstname.lastname@example.org Wim van Harten
Valesca Retèl has a PhD degree in Health Economics and a MSc degree in Health Sciences. Currently, she is Head of the HTA division at the PSOE department for 50% and 50% at the University of Twente (department of Health Technology and Services Research (HTSR)). Her research is focused on early Health Technology Assessments concerning a range of applications such as Next Generation Sequencing, Immunotherapy, big data, Image Guided Surgery and cancer survivorship in oncology. Four of these projects are part of a Coverage with Evidence Development program, which she coordinates within the NKI-AVL. Valesca uses mathematical modeling to combine information on besides cost-effectiveness, organizational issues, ethical-legal, and patient related aspects of promising new technologies in early stages of development. In the early stages, broad spectrum scenario drafting is a key element in these early assessments. She currently supervises 8 PhD students.
Nationally, Valesca is project leader of the €1,8M “Technology Assessment of Next Generation sequencing of personalized Oncology” (TANGO) project.
On an international level, she is coordinator of the Cost-benefit working group of the Organization of European Cancer Institutes (OECI)